icose veins.
Evidence. The efÔ¨Åcacy and safety of VADs was extensively studied in patients with CVD in double-blind, placebo-controlled, randomized trials and meta-analyses.
There have been two Cochrane reviews, the most recent
in 2020, that included a systematic review and metaanalysis of 7690 patients, enrolled in 56 studies.104,105
The VAD used included rutosides,